Capital World Investors
TBPH icon

Capital World Investors’s Theravance Biopharma TBPH Stock Holding History

Capital World Investors’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-371,428
Closed -$4.84M – 541
2015
Q2 		$4.84M Hold
371,428
– – ﹤0.01% 514
2015
Q1 		$6.44M Sell
371,428
-542,000
-59% -$9.94M ﹤0.01% 505
2014
Q4 		$13.6M Sell
913,428
-961,893
-51% -$16.8M ﹤0.01% 471
2014
Q3 		$43.2M Sell
1,875,321
-209,935
-10% -$6.09M 0.01% 380
2014
Q2 		$66.5M Buy
+2,085,256
New +$62.8M 0.02% 339

Other funds holding TBPH

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
FAM
Foundation Asset Management White Plains, New York $116M AUM 31.02% 1-Year Est. Return

Capital World Investors's TBPH Position: Q3 2015 in Review

Capital World Investors sold out of Theravance Biopharma (TBPH) in Q3 2015, closing a stake of 371,428 shares — an estimated $4.84M sold.

Capital World Investors first reported a position in TBPH in Q2 2014 and held it in 5 quarters. The position peaked at $66.5M in Q2 2014. 83 funds tracked by Wall St. Rank hold TBPH as of Q3 2015.

  • Capital World Investors reported no remaining Theravance Biopharma position as of Q3 2015 after selling out during the quarter.
  • Capital World Investors sold 371,428 Theravance Biopharma shares in Q3 2015, an estimated $4.84M.
  • Capital World Investors first reported a position in Theravance Biopharma in Q2 2014 and held it in 5 quarters.
  • Capital World Investors's Theravance Biopharma position peaked at $66.5M in Q2 2014.
  • 83 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2015.

Based on Capital World Investors's 13F filing for Q3 2015, filed 16 Nov 2015.